Significant prognostic factors in 283 patients after surgery for adenocarcinoma of the stomach

Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae

Volumn 78, Issue 1, 2005, Pages 3-16

  Gorbunov, E A ^a   Wechsler, J ^a   Stasek J ^a   Tomin, A S ^b   Solodun, L D ^b  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Adenocarcinoma of the stomach; Prognostic factors; Survival

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ABDOMINAL MASS; ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTRECTOMY; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BYPASS; KAPLAN MEIER METHOD; LAPAROTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PALPATION; PARTIAL GASTRECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROGNOSIS; SEX RATIO; STATISTICAL ANALYSIS; STOMACH ADENOCARCINOMA; STOMACH SURGERY; STOMACH WALL; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME; WEIGHT REDUCTION;

EID: 25844473261     PISSN: 12113395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Parkin DR. Muir CS, Whelan SL, Gao YT Ferlay J, Powell J. eds. Cancer incidence in five continents, 6, IARC Scientific Publication 120. Lyon, 1992: pp. 865-870.
2. Kolcová V Geryk E, Jechová M. Zhoubné novotvary - Česká republika a vybrané státy [Malignant neoplasms - Czech Republic and selected countries]. Galen, 1999.
3. Hangstvedt T Viste A, Eide GE, Real C, Soreide O. The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. World J Surg 1989; 13: 617-622.
4. Gouzi HL, Huguier M, Fagniez PL et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 1989; 209: 162-166.
5. Bozzetti F Regalia E, Bonfanti G, Doci R, Ballarini D, Gennari L. Early and late results of extended surgery for cancer of the stomach. Br J Surg 1990; 77: 53-56.
6. Salvon-Harman JC, Cady B Nikulasson S, Khettry U, Stone MD, Lavin P. Shifting proportions of gastric adenocarcinomas. Arch Surg 1994; 129: 381-389.
7. Stipa S, Di Giorgio A, Ferri M, Botti C. Results of curative gastrectomy for carcinoma. J Am Coll Surg 1994; 179: 567-572.
8. Cady B, Rossi RL, Silverman ML, Piccione W, Heck TA. Gastric adenocarcinoma. A disease in transition. Arch Surg 1989; 124: 303-308.
9. Shiu MH Perrotti M, Brennan MF Adenocarcinoma of the stomach; a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology 1989; 36: 7-12.
10. Rohde H, Gebbensleben B, Bauer P Stautzer H, Zieschang J. Has there been any improvement in the staging of gastric cancer? Findings from the German Gastric Cancer TNM Study Group. Cancer 1989; 64: 2465-2481.
11. Arveux P Faivre J, Boutron MCH et al. Prognosis of gastric carcinoma after curative surgery. A population based study using multivariate crude and relative survival analysis. Dig Dis Sci 1992; 37: 757-763.
12. Brems-Dalgaard E, Clausen HV. Survival following microscopically confirmed radical resection of NO gastric cancer. Br J Surg 1993; 80: 1150-1152.
13. Bollschweiler E, Boettcher K, Hoelscher AH et al. Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer 1993; 71: 2918-2225.
14. Michelassi F, Takanishi DM Jr, Pantalone D, Hart J, Chappell R, Block GE. Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery 1994; 116: 804-810.
15. STATISTICA Cz [Softwarový systém na analýzu dat, verze 6] [A software system for data analysis, version 61. StatSoft, Inc., 2001. www.StatSoft.Cz.
16. Hermanek P, Sobin LH, eds. TNM classification of malignant tumors, 4th ed. Union Internationale Contre le Cancer. Berlin: Springer-Verlag, 1987.
17. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer 1998 Mar; 1(2):125-133.
18. Supervivencia en 2.334 pacientes con cáncer gástrico y factores que modifican el pronóstico. Casariego Vales E, Pita Fernandez S, Rigueiro Veloso MT et al. Med Clin (Barc) 2001 Oct 6; 117(10): 361-365.
19. Maehara Y, Watanabe A, Kakeji Y et al. Prognosis for surgically treated gastric cancer patients is poorer for women than men in all patients under age 50. Br J Cancer 1992; 65: 417-420.
20. Msika S, Chastang C, Houry S, Lacaine F, Huguier M. Lymph node involvement as the only prognostic factor in curative resected gastric carcinoma; a multivariate analysis. World J Surg 1989; 13: 118-123.
21. Meyers WC, Damiano RJ Jr, Rotolo FS, Postlethwait RW. Adenocarcinoma of the stomach. Changing patterns over the last 4 decades. Ann Surg 1987; 205: 1-8.
22. Harrison JD, Fielding JWL. Prognostic factors for gastric cancer influencing clinical practice. World J Surg 1995; 19: 496-500.
23. Calpena R, Medrano J, Del Fresno J et al. Factores que influyen en la supervivencia de los pacientes diagnosticados de cancer gastrico. Cirurgia Espanola 1988; 43: 560-566.
24. Park JG, Gazdar AF Kim YI, Choi BI, Song IS, Kim JP. Gastric cancer in Korea: Experience at Seoul National University Hospital. In: Sugarbaker P. Management of gastric cancer. Boston: Kluwer Academic, 1991: 285-305.
25. Webb JN Busuttil A. Adenocarcinoma of the esophagus and of the esophago-gastric junction. Br J Surg 1978; 65: 475-479.
26. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990; 62: 440-443.
27. Samson PS, Escovidal LA, Yrastorza SG, Veneracion RG, Nerves MY Re-study of gastric cancer: analysis of outcome. World J Surg 2002; 26(4):428-433.
28. Abe S, Shiraishi M, Nagoaka S, Yoshimura H, Dhar DK, Nakamura T Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer. Surgery 1991; 109: 582-588.
29. Matley PJ, Dent DM, Madden MV, Price SK. Gastric carcinoma in young adults. Ann Surg 1988; 208:593-596.
30. Mitsudomi T, Matsusaka T, Wakasugi K et al. A clinicopathological study of gastric cancer with special reference to age of the patients; an analysis of 1630 cases. World J Surg 1989; 13: 225-231.
31. Adachi Y, Kamakura T, Mori M, Baba H, Maehara Y, Sugimachi K. Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 1994; 81:414-416.
32. Keller E, Stautzer H, Heitmann K, Bauer P, Gebbensleben B, Rohde H. Lymph node staging in 872 patients with carcinoma of the stomach and the presumed benefit of lymphadenectomy. German Stomach Cancer TNM Study Group. J Am Coll Surg 1994; 178: 38-46.
33. Kwon SJ, Kim GS. Prognostic significance of lymph node metastasis in advanced carcinoma of the stomach. Br J Surg 1996; 83: 1600-1603.
34. de Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996; 83: 1604-1607.
35. Gall FP Hermanek P. New aspects in the surgical treatment of gastric carcinoma - a comparative study of 1636 patients operated on between 1969 and 1982. Eur J Surg Oncol 1985; 11: 219-225.
36. Gouzi JL, Huguier M, Fagniez PL et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg. 1989; 209(2): 162-166.
37. Santoro E, Garofalo A, Scutari F, Zanarini T, Carlini M, Santoro E Jr. Early gastric cancer: total gastrectomy vs. distal resection. Results of a study of 271 cases. The Italian Stomach Cancer Group (A.C.O.I.-I.S.C.G.). Hepatogastroenterology. 1991; 38(5): 427-429.
38. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer 1998; 1(2): 125-133.
39. Marubini E, Bonfanti G, Bozzetti F et al. A prognostic score for patients resected for gastric cancer. Eur J Cancer 1993; 29A(6): 845-850.
40. Geryk E, Kolcová V Epidemiologická charakteristika vybraných nádorů zažívacího traktu [Epidemiological characteristics of selected tumours of the gastrointestinal tract]. Amireport 2/9: 7-12.
41. Král V, Aujeský R, Neoral Č, Klementa I, Klein J. What is the prognosis for patients with recurrent gastric carcinoma? Rozhl Chir. 1995; 74 (1): 11-12.
42. Čapov I, Wechsler J, Hušek K. Agresívní angiomyxom pelveoperitoneální oblasti [An aggressive angiomyxoma of the pelvioperitoneal region]. Rozhledy Chir 1997; 76 (12): 613-615.
43. Čapov I, Skřička T, Tomek M. Mortalita versus letalita [Mortality vs. lethality]. Plzeňský lékařský sborník, Suppl. 1990; 61: 25-27.
44. Žaloudík J, Dušek L. Karcinom žaludku: úspěch či neúspěch? [Gastric carcinoma: a success or a failure?] Zdrav noviny 2003; 36: 16-17,
45. Duda M, Herman J, Stehlik D. The role of a surgeon in a palliative treatment of tumours. Acta Univ Palacki Olomuc Fac Med 2000; 143: 80-81.
46. Herman J, Duda M, Krǎ I, Pohanka J. Malignant lymphoma of the stomach and small intestine. Čes Slov Gastroenterol 1999; 53: 111-113.
47. Žáková A, Žák J. Nutrični profil a terapie u osob s chronickou pankreatitidou [Nutrition profile and therapy in patients with chronic pancreatitis]. Vnitřní lék 2002; 48(9): 887-890.
48. Vokurka J, Wechsler J, Žák J, Vlček P Čapov L Endoscopic and surgical treatment of bleeding peptic ulcers. Bratisl lék listy 1997; 98 (3): 163-165.
49. Bottaci L, Drew PJ, Hartley JE et al. Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions. Lancet 1997;350(9076): 469-472.